HAS2 and breast cancer: Experimental evidence shows that HA synthesis contributes to tumor supporting microenvironment [109], blocking HA production by knockdown of HAS2 [110] and the use of inhibitors such as 4–Methylumbelliferone [111] inhibits tumorigenesis and metastasis of breast cancer cell lines.